CTLA4 and melanoma: Previous studies have found that anti-CTLA-4 antibody depletes tumor-infiltrating Tregs in the melanoma mouse model, which expressed granulocyte macrophage colony-stimulating factor and Fcγ receptor on macrophages was involved with depletion of Tregs by an anti-CTLA-4 antibody[94].